Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Opticon Medical Inc.

www.opticonmedical.com

Latest From Opticon Medical Inc.

Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007

Highlights from the Q4 2007 review of medical device and in vitro diagnostics/research dealmaking: there was a boost in medical device acquisitions--with patient monitoring in particular, which accounted for about half the total of this period--capping off an impressive year in medtech M&A activity. Of note in the in vitro diagnostics/research space was glucose monitoring, which brought in 60% of the total GM segment's $160 million in financing for the entire year.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Immune Response Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Opticon Medical Inc.
  • Senior Management
  • Daniel J Petrarca, CEO
    Gary M Post, VP, Fin.
    Spencer W Beaufore, Dir., Prod. Dev.
  • Contact Info
  • Opticon Medical Inc.
    Phone: (614) 336-2000
    7001 Post Rd.
    Ste. 100
    Dublin, OH 43016-8309
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register